These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 33298651)

  • 1. [Acute promyelocytic leukemia recurrence diagnosed due to granulocytic sarcoma of the external auditory canal].
    Isshiki T; Yoshizawa Y; Iimura Y; Fukuda K; Suzuki S; Sato Y; Nagasawa T
    Rinsho Ketsueki; 2020; 61(11):1590-1594. PubMed ID: 33298651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [All-trans retinoic acid/arsenic trioxide combination therapy for a patient with acute promyelocytic leukemia on dialysis].
    Nagao R; Hosoba R; Yahagi Y; Gunji T; Uryu H; Hattori D; Momoki M; Yamazaki H
    Rinsho Ketsueki; 2019; 60(10):1431-1435. PubMed ID: 31695003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term survival in an acute promyelocytic leukemia patient with recurrent granulocytic sarcomas: A case report.
    Zhou X; Li C
    Medicine (Baltimore); 2021 Apr; 100(14):e25257. PubMed ID: 33832087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CNS relapses of acute promyelocytic leukemia after all-trans retinoic acid.
    Burry LD; Seki JT
    Ann Pharmacother; 2002 Dec; 36(12):1900-6. PubMed ID: 12452754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Extramedullary relapse in the external auditory canal in a patient with acute promyelocytic leukemia treated with all-trans retinoic acid and autologous peripheral blood stem cell transplantation].
    Yagita M; Onishi R; Yamagata N; Shimazaki C; Kudoh H; Kobayashi M; Hikiji K; Konaka Y
    Rinsho Ketsueki; 1998 Sep; 39(9):709-15. PubMed ID: 9796408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of relapsing acute promyelocytic leukemia by all-trans retinoic acid therapy followed by timed sequential chemotherapy and stem cell transplantation. APL Study Group. Acute promyelocytic leukemia.
    Thomas X; Dombret H; Cordonnier C; Pigneux A; Gardin C; Guerci A; Vekhoff A; Sadoun A; Stamatoullas A; Fegueux N; Maloisel F; Cahn JY; Reman O; Gratecos N; Berthou C; Huguet F; Kotoucek P; Travade P; Buzyn A; de Revel T; Vilque JP; Naccache P; Chomienne C; Degos L; Fenaux P
    Leukemia; 2000 Jun; 14(6):1006-13. PubMed ID: 10865965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relapse in the external auditory canal of acute promyelocytic leukemia after treatment with all-trans retinoic acid.
    Tobita T; Shinjyo K; Yanagi M; Takeshita A; Ohnishi K; Ohno R
    Intern Med; 1997 Jul; 36(7):484-6. PubMed ID: 9240497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of acute promyelocytic leukaemia with all-trans retinoic acid and arsenic trioxide: a paradigm of synergistic molecular targeting therapy.
    Zhou GB; Zhang J; Wang ZY; Chen SJ; Chen Z
    Philos Trans R Soc Lond B Biol Sci; 2007 Jun; 362(1482):959-71. PubMed ID: 17317642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Acute promyelocytic leukemia: state-of-the-art management].
    Asou N
    Rinsho Ketsueki; 2018; 59(6):725-734. PubMed ID: 29973452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. External auditory canal and middle ear relapse of acute promyelocytic leukemia treated with arsenic trioxide: case report and review of the literature.
    Lafayette TC; Coser VM; Brûlé AO; Coser PL; Pereira WV
    J Pediatr Hematol Oncol; 2010 Apr; 32(3):229-32. PubMed ID: 20186102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two successful deliveries of healthy children by a young woman diagnosed and treated during induction and relapsed therapy for acute promyelocytic leukemia.
    Dang CC; Guan YK; Lau NS; Chan SY
    J Oncol Pharm Pract; 2020 Dec; 26(8):2034-2037. PubMed ID: 32279594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral arsenic plus retinoic acid versus intravenous arsenic plus retinoic acid for non-high-risk acute promyelocytic leukaemia: a non-inferiority, randomised phase 3 trial.
    Zhu HH; Wu DP; Du X; Zhang X; Liu L; Ma J; Shao ZH; Ren HY; Hu JD; Xu KL; Wang JW; Song YP; Fang MY; Li J; Yan XY; Huang XJ
    Lancet Oncol; 2018 Jul; 19(7):871-879. PubMed ID: 29884593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new transcriptional variant and small azurophilic granules in an acute promyelocytic leukemia case with NPM1/RARA fusion gene.
    Kikuma T; Nakamachi Y; Noguchi Y; Okazaki Y; Shimomura D; Yakushijin K; Yamamoto K; Matsuoka H; Minami H; Itoh T; Kawano S
    Int J Hematol; 2015 Dec; 102(6):713-8. PubMed ID: 26342691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Myeloidleukemia with external auditory canal granulocytic sarcoma: a case report].
    Wang X; Mang R; Zhou Y
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2015 Jan; 29(1):91-3. PubMed ID: 25966566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The PML-RARalpha fusion protein and targeted therapy for acute promyelocytic leukemia.
    Jing Y
    Leuk Lymphoma; 2004 Apr; 45(4):639-48. PubMed ID: 15160934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Rare Case of Relapsed Pediatric Acute Promyelocytic Leukemia with Skin Involvement by Myeloid Sarcoma.
    Araújo NS; Dos Santos Júnior CJ; Gomes VMDS; Calheiros Leite LA; Bomfim LN; Gusmão AKFDS; Alves MJRG; Romão CMDSB; Batinga AMCS; da Silva MR; de Sousa Rodrigues CF
    Am J Case Rep; 2018 Apr; 19():438-441. PubMed ID: 29650946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arsenic trioxide in the treatment of a patient with multiply recurrent, ATRA-resistant promyelocytic leukemia: a case report.
    Bergstrom SK; Gillan E; Quinn JJ; Altman AJ
    J Pediatr Hematol Oncol; 1998; 20(6):545-7. PubMed ID: 9856675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arsenic trioxide is required in the treatment of newly diagnosed acute promyelocytic leukemia. Analysis of a randomized trial (APL 2006) by the French Belgian Swiss APL group.
    Adès L; Thomas X; Bresler AG; Raffoux E; Spertini O; Vey N; Marchand T; Récher C; Pigneux A; Girault S; Deconinck E; Gardin C; Tournilhac O; Lambert JF; Chevallier P; de Botton S; Lejeune J; Dombret H; Chevret S; Fenaux P
    Haematologica; 2018 Dec; 103(12):2033-2039. PubMed ID: 30026341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arsenic but not all-trans retinoic acid overcomes the aberrant stem cell capacity of PML/RARalpha-positive leukemic stem cells.
    Zheng X; Seshire A; Rüster B; Bug G; Beissert T; Puccetti E; Hoelzer D; Henschler R; Ruthardt M
    Haematologica; 2007 Mar; 92(3):323-31. PubMed ID: 17339181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulsed ATRA as single therapy restores long-term remission in PML-RARalpha-positive acute promyelocytic leukemia patients: real time quantification of minimal residual disease. A pilot study.
    Visani G; Buonamici S; Malagola M; Isidori A; Piccaluga PP; Martinelli G; Ottaviani E; Grafone T; Baccarani M; Tura S
    Leukemia; 2001 Nov; 15(11):1696-700. PubMed ID: 11681409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.